Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis
Samsung Biologics announced that it has reached an agreement with Biogen for the buyout of...
Nasal Covid-19 Vaccine From Bharat Biotech, A Possibility
Bharat Biotech has been granted permission by India’s drug controller to execute standalone phase 3...
Recipharm secures vaccine manufacturing deal
Global contract development and manufacturing organization (CDMO), Recipharm, has inked a deal with a top...
Pandemic Far From Over As New Variants Keep Us On The Edge
KEY POINTS
According to the WHO's top official, present conditions are suitable for COVID-19 to...
Global Stake In The Chinese Biotech Companies Is On A Rise
The biotechnology industry in China is coming of age as a major licencing deal has...
Omicron Specific Vaccine Trials Get Rolled Out By Moderna
Moderna, the US biotech firm, has announced that it has initiated clinical trials of a...
Aposave rebrands to Abacus Medicine Pharma Services
Abacus Medicine Pharma Services is the new name for the healthcare and pharma services company...
By Winter 2023 Moderna eyes Combined COVID 19 And Flu Shot
According to Moderna’s CEO, Stephane Bancel, the company is aiming to bring to the market...
Novartis And Pfizer Stand Tall To Disrupt Biosimilar Space
As per GlobalData’s Thematic Research ecosystem, pharmaceutical giants Novartis and Pfizer are the best-positioned companies...
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to...
Pfizer Inc. and BioNTech SE announced the initiation of a clinical study to evaluate the...
